{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:33:04Z","timestamp":1790343184319,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41409-025-02751-7","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T19:24:44Z","timestamp":1764444284000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-331X","authenticated-orcid":false,"given":"Marta","family":"Villalba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allain-Thibeault","family":"Ferhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gedde-Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-7533","authenticated-orcid":false,"given":"Gerard","family":"Socie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Wolfgang","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-8782","authenticated-orcid":false,"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-9447","authenticated-orcid":false,"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-2868","authenticated-orcid":false,"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-3351","authenticated-orcid":false,"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9331-5145","authenticated-orcid":false,"given":"Matthias","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-5332","authenticated-orcid":false,"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kroeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sengeloev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-9592","authenticated-orcid":false,"given":"Helene","family":"Labussiere-Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1897-0227","authenticated-orcid":false,"given":"Xavier","family":"Poir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-648X","authenticated-orcid":false,"given":"Jordi","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-9965","authenticated-orcid":false,"given":"Bipin","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-1265","authenticated-orcid":false,"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5908-0792","authenticated-orcid":false,"given":"Simona","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-4619","authenticated-orcid":false,"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-808X","authenticated-orcid":false,"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0123","authenticated-orcid":false,"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"2751_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden JA, S\u00e1nchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transpl Basingstoke. 2022;57:1217\u201339. https:\/\/doi.org\/10.1038\/s41409-022-01691-w.","journal-title":"Bone Marrow Transpl Basingstoke"},{"key":"2751_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"key":"2751_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","volume":"60","author":"JR Passweg","year":"2025","unstructured":"Passweg JR, Baldomero H, Atlija M, Kleovoulou I, Witaszek A, Alexander T, et al. The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT. Bone Marrow Transpl. 2025;60:519\u201328. https:\/\/doi.org\/10.1038\/s41409-025-02524-2.","journal-title":"Bone Marrow Transpl"},{"key":"2751_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41409-024-02459-0","volume":"60","author":"JR Passweg","year":"2025","unstructured":"Passweg JR, Baldomero H, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, et al. Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT. Bone Marrow Transpl. 2025;60:227\u201336. https:\/\/doi.org\/10.1038\/s41409-024-02459-0.","journal-title":"Bone Marrow Transpl"},{"key":"2751_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fimmu.2020.00147","volume":"11","author":"PE Rovatti","year":"2020","unstructured":"Rovatti PE, Gambacorta V, Lorentino F, Ciceri F, Vago L. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation. Front Immunol. 2020;11:147 https:\/\/doi.org\/10.3389\/fimmu.2020.00147.","journal-title":"Front Immunol"},{"key":"2751_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","volume":"11","author":"M Eapen","year":"2010","unstructured":"Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang M-J, Arcese W, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11:653\u201360. https:\/\/doi.org\/10.1016\/S1470-2045(10)70127-3.","journal-title":"Lancet Oncol"},{"key":"2751_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-017-0498-8","volume":"10","author":"E Brissot","year":"2017","unstructured":"Brissot E, Labopin M, Stelljes M, Ehninger G, Schwerdtfeger R, Finke J, et al. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. J Hematol OncolJ Hematol Oncol. 2017;10:130 https:\/\/doi.org\/10.1186\/s13045-017-0498-8.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"2751_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41409-022-01725-3","volume":"57","author":"L Lazzari","year":"2022","unstructured":"Lazzari L, Balaguer-Rosell\u00f3 A, Montoro J, Greco R, Hernani R, Lupo-Stanghellini MT, et al. Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia. Bone Marrow Transpl. 2022;57:1389\u201398. https:\/\/doi.org\/10.1038\/s41409-022-01725-3.","journal-title":"Bone Marrow Transpl"},{"key":"2751_CR9","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1182\/blood.2023023697","volume":"143","author":"J Sanz","year":"2024","unstructured":"Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, et al. Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT. Blood. 2024;143:2534\u201343. https:\/\/doi.org\/10.1182\/blood.2023023697.","journal-title":"Blood"},{"key":"2751_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-020-00882-6","volume":"13","author":"J Sanz","year":"2020","unstructured":"Sanz J, Galimard J-E, Labopin M, Afanasyev B, Angelucci E, Ciceri F, et al. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT. J Hematol Oncol. 2020;13:46 https:\/\/doi.org\/10.1186\/s13045-020-00882-6.","journal-title":"J Hematol Oncol"},{"key":"2751_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","volume":"17","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu D-H, Xu L-P, Liu K-Y, Chen H, Chen Y-H, et al. Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison. Biol Blood Marrow Transpl. 2011;17:821\u201330. https:\/\/doi.org\/10.1016\/j.bbmt.2010.08.023.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2751_CR12","doi-asserted-by":"publisher","unstructured":"Yu S, Huang F, Wang Y, Xu Y, Yang T, Fan Z, et al. Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study. Leukemia 2020;34:1433\u201343. https:\/\/doi.org\/10.1038\/s41375-019-0686-3.","DOI":"10.1038\/s41375-019-0686-3"},{"key":"2751_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJMoa1602074","volume":"375","author":"F Milano","year":"2016","unstructured":"Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, et al. Cord-Blood Transplantation in Patients with Minimal Residual Disease. N Engl J Med. 2016;375:944\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1602074.","journal-title":"N Engl J Med"},{"key":"2751_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-017-0502-3","volume":"10","author":"Y-J Chang","year":"2017","unstructured":"Chang Y-J, Wang Y, Liu Y-R, Xu L-P, Zhang X-H, Chen H, et al. Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol. 2017;10:134. https:\/\/doi.org\/10.1186\/s13045-017-0502-3.","journal-title":"J Hematol Oncol"},{"key":"2751_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bmt.2015.305","volume":"51","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Labopin M, Ciceri F, Mohty M, Nagler A. Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transpl. 2016;51:610\u20131. https:\/\/doi.org\/10.1038\/bmt.2015.305.","journal-title":"Bone Marrow Transpl"},{"key":"2751_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41409-020-0835-3","volume":"55","author":"A Spyridonidis","year":"2020","unstructured":"Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, et al. Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone Marrow Transpl. 2020;55:1213. https:\/\/doi.org\/10.1038\/s41409-020-0835-3.","journal-title":"Bone Marrow Transpl"},{"key":"2751_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2307\/2281868","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc. 1958;53:457\u201381. https:\/\/doi.org\/10.2307\/2281868.","journal-title":"J Am Stat Assoc"},{"key":"2751_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695\u2013706. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19990330)18:6%253C695::aid-sim60%253E3.0.co;2-o.","journal-title":"Stat Med"},{"key":"2751_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2307\/2670170","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc. 1999;94:496\u2013509. https:\/\/doi.org\/10.2307\/2670170.","journal-title":"J Am Stat Assoc"},{"key":"2751_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression Models and Life-Tables. J R Stat Soc Ser B Methodol. 1972;34:187\u2013220.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"2751_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1177\/0962280216647981","volume":"27","author":"L Biard","year":"2018","unstructured":"Biard L, Labopin M, Chevret S, Resche-Rigon M. Acute Leukaemia Working Party of the EBMT. Investigating covariate-by-centre interaction in survival data. Stat Methods Med Res. 2018;27:920\u201332. https:\/\/doi.org\/10.1177\/0962280216647981.","journal-title":"Stat Methods Med Res"},{"key":"2751_CR22","unstructured":"Therneau TM, Crowson CS, Atkinson EJ. Adjusted Survival Curves. Mayo Clinic; 2015. Available at: https:\/\/cran.r-project.org\/web\/packages\/survival\/vignettes\/survfit.pdf. Accessed 21 November 2025."},{"key":"2751_CR23","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1200\/JCO.2010.28.6856","volume":"28","author":"RF Schlenk","year":"2010","unstructured":"Schlenk RF, D\u00f6hner K, Mack S, Stoppel M, Kir\u00e1ly F, G\u00f6tze K, et al. Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A. J Clin Oncol. 2010;28:4642\u20138. https:\/\/doi.org\/10.1200\/JCO.2010.28.6856.","journal-title":"J Clin Oncol"},{"key":"2751_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-016-0321-y","volume":"9","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Battipaglia G, Labopin M, Ehninger G, Beelen D, Tischer J, et al. Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study. J Hematol Oncol. 2016;9:89. https:\/\/doi.org\/10.1186\/s13045-016-0321-y.","journal-title":"J Hematol Oncol"},{"key":"2751_CR25","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.bbmt.2016.07.010","volume":"22","author":"SR Solomon","year":"2016","unstructured":"Solomon SR, Sizemore CA, Zhang X, Brown S, Holland HK, Morris LE, et al. Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia. Biol Blood Marrow Transpl. 2016;22:1816\u201322. https:\/\/doi.org\/10.1016\/j.bbmt.2016.07.010.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2751_CR26","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","volume":"119","author":"W Saber","year":"2012","unstructured":"Saber W, Opie S, Rizzo JD, Zhang M-J, Horowitz MM, Schriber J. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 2012;119:3908\u201316. https:\/\/doi.org\/10.1182\/blood-2011-09-381699.","journal-title":"Blood"},{"key":"2751_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","volume":"11","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, Afanasyev B, Cornelissen JJ, Elmaagacli A, et al. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. J Hematol Oncol. 2018;11:40. https:\/\/doi.org\/10.1186\/s13045-018-0586-4.","journal-title":"J Hematol Oncol"},{"key":"2751_CR28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3324\/haematol.2018.189258","volume":"103","author":"D Salvatore","year":"2018","unstructured":"Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, et al. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2018;103:1317\u201328. https:\/\/doi.org\/10.3324\/haematol.2018.189258.","journal-title":"Haematologica"},{"key":"2751_CR29","doi-asserted-by":"publisher","unstructured":"Penack O, Abouqateb M, Peczynski C, Boreland W, Benakli M, Kr\u00f6ger N, et al. GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party. Leukemia 2025. https:\/\/doi.org\/10.1038\/s41375-025-02619-1.","DOI":"10.1038\/s41375-025-02619-1"},{"key":"2751_CR30","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","volume":"11","author":"O Penack","year":"2024","unstructured":"Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte RF, et al. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2024;11:e147\u201359. https:\/\/doi.org\/10.1016\/S2352-3026(23)00342-3.","journal-title":"Lancet Haematol"},{"key":"2751_CR31","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","volume":"5","author":"AE DeZern","year":"2021","unstructured":"DeZern AE, Franklin C, Tsai H-L, Imus PH, Cooke KR, Varadhan R, et al. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide. Blood Adv. 2021;5:1360\u20138. https:\/\/doi.org\/10.1182\/bloodadvances.2020003922.","journal-title":"Blood Adv"},{"key":"2751_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01032-8","volume":"14","author":"O Penack","year":"2024","unstructured":"Penack O, Abouqateb M, Peczynski C, Boreland W, G\u00fclbas Z, Gedde-Dahl T, et al. PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation. Blood Cancer J. 2024;14:45. https:\/\/doi.org\/10.1038\/s41408-024-01032-8.","journal-title":"Blood Cancer J"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02751-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02751-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02751-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T23:02:53Z","timestamp":1771282973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02751-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2751"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02751-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The scientific board of the ALWP of EBMT approved this study. All patients gave written informed consent for the use of their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}